PL2437739T3 - Leczenie zapalenia kłębuszków nerkowych - Google Patents
Leczenie zapalenia kłębuszków nerkowychInfo
- Publication number
- PL2437739T3 PL2437739T3 PL10722643T PL10722643T PL2437739T3 PL 2437739 T3 PL2437739 T3 PL 2437739T3 PL 10722643 T PL10722643 T PL 10722643T PL 10722643 T PL10722643 T PL 10722643T PL 2437739 T3 PL2437739 T3 PL 2437739T3
- Authority
- PL
- Poland
- Prior art keywords
- glomerulonephritis
- treatment
- glomerulonephritis treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/227—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0909643A GB0909643D0 (en) | 2009-06-04 | 2009-06-04 | Glomerulonephritis treatment |
| EP10722643.3A EP2437739B1 (en) | 2009-06-04 | 2010-06-04 | Glomerulonephritis treatment |
| PCT/EP2010/003384 WO2010139482A1 (en) | 2009-06-04 | 2010-06-04 | Glomerulonephritis treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2437739T3 true PL2437739T3 (pl) | 2015-11-30 |
Family
ID=40936918
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14158421T PL2745837T3 (pl) | 2009-06-04 | 2010-06-04 | Leczenie zapalenia kłębuszków nerkowych |
| PL10722643T PL2437739T3 (pl) | 2009-06-04 | 2010-06-04 | Leczenie zapalenia kłębuszków nerkowych |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14158421T PL2745837T3 (pl) | 2009-06-04 | 2010-06-04 | Leczenie zapalenia kłębuszków nerkowych |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US20120136066A1 (pl) |
| EP (2) | EP2437739B1 (pl) |
| JP (1) | JP5837481B2 (pl) |
| AU (1) | AU2010256013B2 (pl) |
| CA (1) | CA2764465C (pl) |
| CY (1) | CY1118269T1 (pl) |
| DK (2) | DK2745837T3 (pl) |
| ES (2) | ES2587719T3 (pl) |
| GB (1) | GB0909643D0 (pl) |
| HU (2) | HUE027050T2 (pl) |
| LT (1) | LT2745837T (pl) |
| PL (2) | PL2745837T3 (pl) |
| PT (2) | PT2437739E (pl) |
| WO (1) | WO2010139482A1 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201014633D0 (en) * | 2010-09-02 | 2010-10-13 | Avexxin As | Rheumatoid arthritis treatment |
| GB201205394D0 (en) | 2012-03-27 | 2012-05-09 | Adlens Ltd | Improvements in or relating to deformable non-round membrane assemblies |
| GB201221329D0 (en) | 2012-11-27 | 2013-01-09 | Avexxin As | Dermatitis treatment |
| GB201313238D0 (en) | 2013-07-24 | 2013-09-04 | Avexxin As | Process for the preparation of a polyunsaturated ketone compound |
| GB201409363D0 (en) | 2014-05-27 | 2014-07-09 | Avexxin As | Skin cancer treatment |
| GB201501144D0 (en) | 2015-01-23 | 2015-03-11 | Avexxin As | Process for the preparation of a polyunsaturated ketone compound |
| GB201604316D0 (en) | 2016-03-14 | 2016-04-27 | Avexxin As | Combination therapy |
| AU2017329957B2 (en) | 2016-09-21 | 2020-05-07 | Avexxin As | Pharmaceutical composition |
| JP7305562B2 (ja) * | 2017-06-16 | 2023-07-10 | アヴェクシン エーエス | 線維性疾患の治療のための組成物および方法 |
| GB201910644D0 (en) | 2019-07-25 | 2019-09-11 | Coegin Pharma As | Cancer Treatment |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4670465A (en) * | 1986-05-21 | 1987-06-02 | Syntex (U.S.A.) Inc. | Arachidonic acid analogs |
| JPH0987176A (ja) * | 1995-09-26 | 1997-03-31 | Shiseido Co Ltd | 糸球体腎炎抑制剤 |
| JPH09268153A (ja) | 1996-04-02 | 1997-10-14 | Sagami Chem Res Center | トリフルオロメチルケトン誘導体及びホスホリパーゼａ２阻害剤 |
| JP2000508645A (ja) * | 1996-04-12 | 2000-07-11 | ペプテック リミテッド | ポリ不飽和脂肪酸を使用する免疫病の治療方法 |
| US6107334A (en) | 1998-02-23 | 2000-08-22 | Wake Forest University | Dietary control of arachidonic acid metabolism |
| AU4994899A (en) | 1998-07-13 | 2000-02-01 | University Of South Florida | Modulation of the phospholipase a2 pathway as a therapeutic |
| US6031014A (en) * | 1998-12-08 | 2000-02-29 | Crivello; James V. | Initiator compositions and methods for their synthesis and use |
| US20020165119A1 (en) * | 2001-01-31 | 2002-11-07 | Alan Leff | Method of treating inflammatory conditions by inhibiting cytosolic phospholipase A2 |
| GB0202002D0 (en) * | 2002-01-29 | 2002-03-13 | Leiv Eiriksson Nyotek A S | Use |
| MY131170A (en) * | 2002-03-28 | 2007-07-31 | Nissan Chemical Ind Ltd | Therapeutic agent for glomerular disease |
| US20060159746A1 (en) * | 2003-03-18 | 2006-07-20 | Troup John P | Compositions comprising fatty acids and amino acids |
| WO2008075366A2 (en) * | 2006-12-20 | 2008-06-26 | Medwell Laboratories Ltd. | Novel conjugates of polyunsaturated fatty acids with amines and therapeutic uses thereof |
| NZ552238A (en) * | 2006-12-20 | 2009-07-31 | Seperex Nutritionals Ltd | An extract |
| ES2733353T3 (es) * | 2007-11-09 | 2019-11-28 | Basf As | Compuestos lípidos para uso en productos cosméticos, como suplemento alimenticio o como un medicamento |
-
2009
- 2009-06-04 GB GB0909643A patent/GB0909643D0/en not_active Ceased
-
2010
- 2010-06-04 AU AU2010256013A patent/AU2010256013B2/en not_active Ceased
- 2010-06-04 CA CA2764465A patent/CA2764465C/en active Active
- 2010-06-04 EP EP10722643.3A patent/EP2437739B1/en not_active Not-in-force
- 2010-06-04 PL PL14158421T patent/PL2745837T3/pl unknown
- 2010-06-04 PT PT107226433T patent/PT2437739E/pt unknown
- 2010-06-04 ES ES14158421.9T patent/ES2587719T3/es active Active
- 2010-06-04 ES ES10722643.3T patent/ES2546198T3/es active Active
- 2010-06-04 US US13/375,618 patent/US20120136066A1/en not_active Abandoned
- 2010-06-04 US US12/794,367 patent/US8796251B2/en active Active
- 2010-06-04 EP EP14158421.9A patent/EP2745837B1/en not_active Not-in-force
- 2010-06-04 HU HUE10722643A patent/HUE027050T2/en unknown
- 2010-06-04 JP JP2012513512A patent/JP5837481B2/ja not_active Expired - Fee Related
- 2010-06-04 HU HUE14158421A patent/HUE030085T2/en unknown
- 2010-06-04 DK DK14158421.9T patent/DK2745837T3/en active
- 2010-06-04 PT PT141584219T patent/PT2745837T/pt unknown
- 2010-06-04 DK DK10722643.3T patent/DK2437739T3/en active
- 2010-06-04 LT LTEP14158421.9T patent/LT2745837T/lt unknown
- 2010-06-04 PL PL10722643T patent/PL2437739T3/pl unknown
- 2010-06-04 WO PCT/EP2010/003384 patent/WO2010139482A1/en active Application Filing
-
2014
- 2014-03-07 US US14/200,238 patent/US9187396B2/en not_active Expired - Fee Related
-
2016
- 2016-08-24 CY CY20161100833T patent/CY1118269T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1118269T1 (el) | 2017-06-28 |
| US20140256824A1 (en) | 2014-09-11 |
| AU2010256013A1 (en) | 2012-01-12 |
| PT2745837T (pt) | 2016-08-22 |
| US9187396B2 (en) | 2015-11-17 |
| HUE030085T2 (en) | 2017-04-28 |
| WO2010139482A1 (en) | 2010-12-09 |
| CA2764465A1 (en) | 2010-12-09 |
| AU2010256013B2 (en) | 2013-05-16 |
| US8796251B2 (en) | 2014-08-05 |
| EP2745837A1 (en) | 2014-06-25 |
| US20120136066A1 (en) | 2012-05-31 |
| LT2745837T (lt) | 2016-10-25 |
| JP2012528813A (ja) | 2012-11-15 |
| PT2437739E (pt) | 2015-10-12 |
| ES2587719T3 (es) | 2016-10-26 |
| EP2437739B1 (en) | 2015-07-29 |
| EP2745837B1 (en) | 2016-07-27 |
| HUE027050T2 (en) | 2016-08-29 |
| GB0909643D0 (en) | 2009-07-22 |
| US20100311843A1 (en) | 2010-12-09 |
| DK2437739T3 (en) | 2015-08-17 |
| DK2745837T3 (en) | 2016-08-29 |
| ES2546198T3 (es) | 2015-09-21 |
| EP2437739A1 (en) | 2012-04-11 |
| PL2745837T3 (pl) | 2017-01-31 |
| JP5837481B2 (ja) | 2015-12-24 |
| CA2764465C (en) | 2018-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1175476A1 (en) | Cancer treatment | |
| HUE056278T2 (hu) | Elhízás kezelése | |
| PL2652193T3 (pl) | Obróbka | |
| GB0920112D0 (en) | Treatment device | |
| EP2409634A4 (en) | ENDOSCOPE OF TREATMENT | |
| LT2405869T (lt) | Nutukimo gydymas | |
| EP2493820A4 (en) | WATER TREATMENT | |
| GB0915515D0 (en) | Treatment of vasculoproliferative conditions | |
| PL2437739T3 (pl) | Leczenie zapalenia kłębuszków nerkowych | |
| GB0900599D0 (en) | Treatment | |
| GB201013898D0 (en) | Well treatment | |
| GB201013573D0 (en) | Treatment | |
| GB201001521D0 (en) | Treatment | |
| GB0913968D0 (en) | Treatment | |
| PL2263454T3 (pl) | Kompozycja uzdatniająca | |
| IL213287A0 (en) | Treatment for glomerulonephritis | |
| GB201014097D0 (en) | Treatment | |
| GB0906010D0 (en) | Acne treatment | |
| GB0914581D0 (en) | Well treatment | |
| GB0916542D0 (en) | Well treatment | |
| GB201001517D0 (en) | Treatment | |
| GB0921303D0 (en) | Treatment process | |
| GB0912839D0 (en) | Water treatment | |
| GB0915801D0 (en) | Theraputic treatment | |
| GB0914820D0 (en) | WATerian therapy |